Abstract

following parameters were analyzed: age, history of pelvic surgery, anticoagulant therapy (ACT), diabetes, tumor characteristics, total dose, dose/fr, CTV, PTV and DVHs. Univariate (UVAs) and multivariate analysis (MVAs) were used to identify parameters impacting on RTOG grade $2 toxicity and bleeding. Logistic regression was used for the analysis of 5-year toxicity and bleeding. Significant thresholds were identified by ROC analysis. Results:Median follow-upwas65 months(range: 6to161).Medianage was70years(45-83). Historyofpelvicsurgery, ACTand diabetes were observedin 12%, 21% and 6% of pts, respectively. Five-year grade $2 toxicity probabilities were: 15% (IC 95%: 822%),18%(IC 95%:10-25%)and26%(IC 95%:16-36%)forptsreceiving70Gy(2Gy/fr), 70Gy(2.5Gy/fr)and80Gy(2Gy/fr), respectively.Intheentireseries:ACTincreasedtheriskofrectalbleeding(p= 0.03;RR= 1.7).Totaldoseof80Gycomparedto70 Gy increased the 5-year grade $ 2 toxicity risk (OR = 3.35; p = 0.04). In the 70 Gy (2 Gy/fr) pts series, UVAs revealed that rectal wall volumes (in %) corresponding to 70 Gy (V70) increased the risk of bleeding (p = 0.04; RR = 1.1). Rectal wall V69 in % (p = 0.03; RR = 1.1) as well as age (p = 0.04; RR = 1.2) increased the risk of grade $ 2 toxicity. In the 80 Gy pts series, UVAs shows that rectal wall V41 to V73 (in %) and V52 to V69 (in %) increased the risk of grade $ 2 toxicity and bleeding, respectively (p\0.05). Rectal wall V63 (in %, as continuous variable) was predictor of toxicity (p = 0.002; RR = 1.1) and rectal bleeding (p\0.02; RR = 1.1). The RR for grade $ 2 toxicity and bleeding were 5.3 and 3.2 respectively, if V63.32% (p\0.02); median value of V63 being 32%. Whole rectal volume DVHs were not correlated with toxicity. Conclusions: Use of ACT increased the risk of rectal bleeding. Total dose of 80 Gy increased the risk of late rectal toxicity. Rectal wallDVHs(in%onlyandnotinwholevolume)weresignificantlycorrelatedwithtoxicity(V69incaseofatotaldoseof70Gyand V41 to V73 in case of 80 Gy). Recent techniques such as intensity modulated and image guided radiotherapy should be used to decrease rectal dose and therefore complications.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call